Home/ Supplements/ D Aspartic Acid/ Norateen Heavy Weight II

Norateen Heavy Weight II

product on market Tablet or Pill LA Muscle Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 17% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile includes D-Aspartic Acid and Mucuna Pruriens, which are studied for their roles in hormonal support, though evidence for muscle growth remains limited. Beta-Ecdysterone and Methoxyisoflavone are included for potential anabolic effects, but strong clinical data in humans is lacking. Overall, the evidence coverage for these ingredients is minimal.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Norateen Heavy Weight II
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
180
Servings
Other Combinations
Product Type
17%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1200 mg
Market median: 2000.0mg (63 products)
Mucuna Pruriens
600 mg
Suma
120 mg
Beta-Ecdysterone
90 mg
Methoxyisoflavone
60 mg
60 IU
2.7× RDA — within safe limits 179 studies (A:3, B:90)
Market median: 2000.0mg (63 products)
Mucuna Pruriens
100 mg
Suma
20 mg
beta-Ecdysterone
15 mg
Methoxyisoflavone
10 mg
10 IU
Within RDA (0.4× RDA) 179 studies (A:3, B:90)
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Formulation Notes

Powerful muscle builder

100% safe & natural

1200 mg D-aspartic acid

Scientifically formulated

Additional Information

cGMP Certified

Metadata

Product Details

DSLD Entry Date2022-02-23
Product TypeOther Combinations
FormTablet or Pill
DSLD ID266366
Data Updated2026-04-11
Research

Research Evidence

9
Research Sources
37
Avg Quality
5
Rct
4
Other
C The Effects of Six-Gram D-Aspartic Acid Supplementation on the Testosterone, Cortisol, and Hematological Responses of Male Boxers Subjected to 11 Days of Nocturnal Exposure to Normobaric Hypoxia
Rct Nutrients 2023 PubMed DOI
C Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine
Rct Journal of psychopharmacology (Oxford, England) 2012 PubMed DOI
C The effects of d-aspartic acid supplementation in resistance-trained men over a three month training period: A randomised controlled trial
Rct PloS one 2017 PubMed DOI
C Short-Term d-Aspartic Acid Supplementation Does Not Affect Serum Biomarkers Associated With the Hypothalamic-Pituitary-Gonadal Axis in Male Climbers
Rct International journal of sport nutrition and exercise metabolism 2019 PubMed DOI
C Combined melatonin and adrenocorticotropic hormone treatment attenuates N-methyl-d-aspartate-induced infantile spasms in a rat model by regulating activation of the HPA axis
Other Neuroscience letters 2021 PubMed DOI
D A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain
Rct Anesthesia and analgesia 2004 PubMed DOI
D The efficacy of adrenocorticotropic hormone in a girl with anti-N-methyl-D-aspartate receptor encephalitis
Other Brain & development 2018 PubMed DOI
D The role and molecular mechanism of D-aspartic acid in the release and synthesis of LH and testosterone in humans and rats
Other Reproductive biology and endocrinology : RB&E 2009 PubMed DOI
F Blockage of N-methyl-D-aspartate receptors decreases testosterone levels and enhances postnatal neuronal apoptosis in the preoptic area of male rats
Other Neuroendocrinology 2000 PubMed
View all evidence for D Aspartic Acid →
Compare

Similar Products

View all D Aspartic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.